Loading clinical trials...
Loading clinical trials...
A Phase II Study of Bortezomib in Combination With Dexamethasone in Patients With Relapsed Hodgkin's Lymphoma
Conditions
Interventions
Bortezomib
Dexamethasone
Locations
1
Germany
University of Cologne
Cologne, North Rhine-Westphalia, Germany
Start Date
March 1, 2005
Last Updated
July 10, 2008
NCT07209059
NCT02287311
NCT07449832
NCT04998331
NCT02057185
NCT01858922
Lead Sponsor
University of Cologne
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions